Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Plasma GFAP voorspelt veranderingen in MRI-markers bij cSVD
mei 2026 | Neuro-vasculair